Literature DB >> 5144531

The relationship between thymus and oncogenesis. A study of the incidence of non thymic malignancy in myasthenia gravis.

A E Papatestas, K E Osserman, A E Kark.   

Abstract

The records of 1243 patients with myasthenia gravis (M.G.) have been reviewed in a retrospective study of the incidence of extrathymic neoplasms. Ninety-four malignant neoplasms were traced.The onset of the disease (M.G.) coincided with a marked increase in the incidence of extrathymic neoplasms. The observed number of neoplasms in the year of onset of M.G. was three times higher than the expected in a control group. This was in sharp contrast to the lower than expected incidence in the years preceding the onset of M.G.The incidence remained at higher than the expected levels throughout the course of the disease in patients who did not undergo thymectomy, while in those patients who had thymectomy the incidence decreased to the levels of the general population after the second postoperative year.These observations suggest an oncogenic thymic influence. The possibility is discussed of the potential oncogenic role of abnormal clones of immunocompetent small lymphocytes of thymic origin.

Entities:  

Mesh:

Year:  1971        PMID: 5144531      PMCID: PMC2008859          DOI: 10.1038/bjc.1971.79

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  9 in total

1.  An evaluation of thymectomy in myasthenia gravis.

Authors:  J A SIMPSON
Journal:  Brain       Date:  1958-03       Impact factor: 13.501

2.  Spontaneous mammary adenocarcinoma in mice: influence of thymectomy and reconstitution with thymus grafts or spleen cells.

Authors:  E J Yunis; C Martinez; J Smith; O Stutman; R A Good
Journal:  Cancer Res       Date:  1969-01       Impact factor: 12.701

3.  Myasthenia gravis, chronic lymphocytic leukemia, and autoimmune hemolytic anemia. "A spectrum of thymic abnormalities?

Authors:  S M Cohen; S Waxman
Journal:  Arch Intern Med       Date:  1967-12

4.  The association of immune disease and malignant lymphoma.

Authors:  D G Miller
Journal:  Ann Intern Med       Date:  1967-03       Impact factor: 25.391

5.  Thymoma and cancer.

Authors:  J V Souadjian; M N Silverstein; J L Titus
Journal:  Cancer       Date:  1968-12       Impact factor: 6.860

6.  The role of thymectomy in the treatment of myasthenia gravis.

Authors:  V P Perlo; B Arnason; D Poskanzer; B Castleman; R S Schwab; K E Osserman; A Papatestis; L Alpert; A Kark
Journal:  Ann N Y Acad Sci       Date:  1971-09-15       Impact factor: 5.691

Review 7.  Myasthenia as an autoimmune disease: clinical aspects.

Authors:  S M Wolf; L P Rowland; D L Schotland; A S McKinney; P F Hoefer; H Aranow
Journal:  Ann N Y Acad Sci       Date:  1966-01-26       Impact factor: 5.691

8.  The association of rheumatoid arthritis with plasma cell and lymphocytic neoplasms.

Authors:  G J Goldenberg; F Paraskevas; L G Israels
Journal:  Arthritis Rheum       Date:  1969-12

9.  Studies in myasthenia gravis: effects of thymectomy. Results on 185 patients with nonthymomatous and thymomatous myasthenia gravis, 1941-1969.

Authors:  A E Papatestas; L I Alpert; K E Osserman; R S Osserman; A E Kark
Journal:  Am J Med       Date:  1971-04       Impact factor: 4.965

  9 in total
  15 in total

1.  Myasthenia gravis associated with a hormone producing malignant carcinoid tumour.

Authors:  S J Wroe; M Ardron; A N Bowden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-07       Impact factor: 10.154

2.  Immunologic response in vitro after thymechtomy in patients with myasthenia gravis.

Authors:  T Bowen; H F Pabst
Journal:  Can Med Assoc J       Date:  1976-10-09       Impact factor: 8.262

3.  Association of myasthenia gravis and polymyositis with neoplasia, infection and autoimmune disorders.

Authors:  W M Behan; P O Behan; D Doyle
Journal:  Acta Neuropathol       Date:  1982       Impact factor: 17.088

4.  Non-small-cell lung cancer associated with non-thymomatous myasthenia gravis.

Authors:  Yasushi Sakamaki; Hyung-Eun Yoon; Naofumi Oda
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2006-05

5.  Myasthenia gravis.

Authors:  R Anandam
Journal:  Indian J Pediatr       Date:  1989 Mar-Apr       Impact factor: 1.967

Review 6.  Update on myasthenia gravis.

Authors:  B R Thanvi; T C N Lo
Journal:  Postgrad Med J       Date:  2004-12       Impact factor: 2.401

7.  The immunological effects of thymectomy in myasthenia gravis.

Authors:  G K Scadding; H C Thomas; C W Havard
Journal:  Clin Exp Immunol       Date:  1979-05       Impact factor: 4.330

8.  Myasthenia gravis with thymoma associated with occult thyroid carcinoma.

Authors:  O Senga; H Hikita; T Kinoshita; K Hara; M Miyakawa
Journal:  Surg Today       Date:  1992       Impact factor: 2.549

9.  Effects of thymectomy in myasthenia gravis.

Authors:  A E Papatestas; G Genkins; P Kornfeld; J B Eisenkraft; R P Fagerstrom; J Pozner; A H Aufses
Journal:  Ann Surg       Date:  1987-07       Impact factor: 12.969

10.  Risk factors for tumor occurrence in patients with myasthenia gravis.

Authors:  Antonietta Citterio; Ettore Beghi; Andrea Millul; Amelia Evoli; Renato Mantegazza; Carlo Antozzi; Fulvio Baggi; Ferdinando Cornelio; Luca Durelli; Marinella Clerico; Giovanni Piccolo; Vittorio Cosi
Journal:  J Neurol       Date:  2009-03-29       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.